PUBLISHER: TechNavio | PRODUCT CODE: 1101614
PUBLISHER: TechNavio | PRODUCT CODE: 1101614
Technavio has been monitoring the immunosuppressants market and it is poised to grow by $ 6.99 bn during 2022-2026, accelerating at a CAGR of 7.73% during the forecast period. Our report on the immunosuppressants market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by reimbursement policies for kidney transplantation, rising prevalence of autoimmune diseases, and increasing road accidents.
The immunosuppressants market analysis includes the drug class and geographic landscape.
Technavio's immunosuppressants market is segmented as below:
By Drug Class
By Geographical Landscape
This study identifies the high dependency on immunosuppressants for kidney transplantation as one of the prime reasons driving the immunosuppressants market growth during the next few years. Also, increase in use of tissue engineering for generation of implants and rise in disposable income in developing economies will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on immunosuppressants market covers the following areas:
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading immunosuppressants market vendors that include AbbVie Inc., Accord Healthcare Ltd., Astellas Pharma Inc., Belcher Pharmaceuticals LLC, Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson, LEO Pharma AS, Livzon Pharmaceutical Group Inc., Novartis AG, Pfizer Inc., RPG Life Sciences Ltd., Sanofi, Sebela Pharmaceuticals Inc., TFF Pharmaceuticals Inc., and Viatris Inc. Also, the immunosuppressants market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: